Dr. Ivana Barbaric discusses how genetic mutations in hPSCs cultured in vitro confer selective advantages that can affect cell behavior and confound experimental results through the elimination of wild-type cells. Dr. Barbaric is a group leader at the Center for Stem Cell Biology, University of Sheffield, UK.
To view the webinar, please complete the form, or sign in to your account.